Month: January 2024

Phase I/II trial assessing the safety and efficacy of RECCE® 327 (R327), a broad-spectrum anti-infective as a topical treatment, met all primary endpoints R327 was well-tolerated in all patients, resolving mild skin and soft tissue diabetic foot infections (DFI), including multidrug-resistant Gram-positive and Gram-negative pathogens Data supports imminent domestic and international site expansionSYDNEY, Australia, Jan. 23, 2024 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (the Company), the Company developing a new class of synthetic anti-infectives, today announced positive results from a Phase I/II trial assessing the safety and efficacy of its lead synthetic anti-infective candidate, RECCE® 327 (R327), in patients with diabetic foot infections (DFI). “We are pleased that the Phase I/II clinical trial...

FREMONT, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, announced today that it will host a conference call and webcast on Tuesday, Feb. 6, 2024 at 4:30 p.m. Eastern Time to discuss its fourth quarter and full year 2023 financial results for the period ended Dec. 31, 2023. The live webcast can be accessed on the Enphase Energy Investor Relations website at investor.enphase.com, and a recorded version of the call will also be available there approximately one hour after the call.What: Enphase Energy’s Fourth Quarter and Full Year 2023 Financial Results Earnings Conference Call and Webcast   Date: Tuesday, Feb. 6, 2024   Time: 4:30 p.m. Eastern Time   Live...

SAN DIEGO, Jan. 23, 2024 (GLOBE NEWSWIRE) —  Genasys Inc. (NASDAQ: GNSS), the global leader in protective communications, today announced plans to release financial results for its fiscal first quarter, ended December 31, 2023, after the market close on Tuesday, February 13, 2024. A conference call to discuss the fiscal first quarter 2024 financial results will be held at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. Conference call details: Date: February 13, 2024Time: 4:30 p.m. Eastern / 1:30 p.m. Pacific Toll-Free Dial-In Number: (888) 390-3967 (U.S. & Canada)International Dial-In Number: (862) 298-0702Webcast: https://www.webcaster4.com/Webcast/Page/1375/49779 Please dial in 10 minutes prior to the start time and tell the operator you are calling in for the Genasys Fiscal First Quarter 2024 Financial Results Call. Questions...

DENVER, Jan. 23, 2024 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2024 fiscal second quarter financial results on Tuesday, February 6, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company’s website, https://investor.innovage.com/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for a limited time. To access...

BURLINGTON, Mass., Jan. 23, 2024 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, will announce its first quarter financial results for the quarter ended December 31, 2023 on Tuesday, February 6, 2024 at 7:00 a.m. Eastern Time / 4:00 a.m. Pacific Time. The company will host a live conference call and webcast, with accompanying slides, to discuss the results on the same day at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Interested investors and analysts are invited to join the audio conference call by registering here. Webcast access will be available in the Investor Information section of the company’s website at www.cerence.com. The teleconference replay will be available through February 20, 2024. The webcast replay will be available on the Company’s website at www.cerence.com. To learn more about...

CALGARY, Alberta, Jan. 23, 2024 (GLOBE NEWSWIRE) — Pulse Oil Corp. (the “Company” or “Pulse”) (TSXV: PUL) reports the completion of the rights offering (the “Rights Offering”) to eligible holders of its common shares (the “Common Shares”), announced in its news release of December 7, 2023. Pursuant to the Rights Offering, the Company issued a total of 103,910,942 Common Shares, the full amount of the Rights Offering, at a price of $0.04 per Common Share for aggregate gross proceeds of $4,156,437.68. A total of 49,074,871 Common Shares were issued under the basic subscription privilege, including 39,889,286 Common Shares to insiders of the Company, as a group, and 6,786,000 Common Shares to all other persons (“Non-Insiders”), as a group. In addition, a total of 2,399,585 Common Shares were issued under the additional subscription...

MINNEAPOLIS, MN, Jan. 23, 2024 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application related to the Company’s proprietary biomaterials and corresponding products. The broad scope of the issued claims in this patent, entitled “Protein Biomaterials and Biocoacervates and Methods of Making and Using Thereof” provides protection for a broad range of proprietary products, including the biocompatible sponge-like particles used in PetVivo’s signature product, Spryng™ with OsteoCushion™ Technology. “We are...

Pharmaloz Wins Two New Contracts in January that are Anticipated to Significantly Increase Lozenge Revenues and ProfitabilityCompany in Late-Stage Discussions with Two Additional Large Global Brands Which, if Consummated, Could more than Triple Run-Rate of Revenues Before Year-End 2024 Garden City, NY, Jan. 23, 2024 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics, therapeutics and diagnostics company, today announces significant progress at Pharmaloz Manufacturing, Inc. (PMI), its wholly owned subsidiary. With the implementation of recent price increases across its entire product line, PMI has transitioned to significant projected 2024 profitability starting with Q1 2024. In view of favorable current market conditions and demand for PMI’s services and...

Ships more than 60 SRT units in 2023To report full financial results and hold conference call on February 8th BOCA RATON, Fla. , Jan. 23, 2024 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announces preliminary unaudited financial results for the three and 12 months ended December 31, 2023. The company expects to report revenue for the fourth quarter of 2023 of more than $12 million, with full-year revenue expected to exceed $23 million.   “We are delighted to report a strong uptick in our business during the fourth quarter and to achieve our guidance to ship more than 60 SRT systems during 2023,” said Joe Sardano, chairman and chief executive...

EL PASO, Texas, Jan. 23, 2024 (GLOBE NEWSWIRE) — Lenders One® Cooperative (“L1” or “Lenders One”), a national alliance of independent mortgage bankers, banks and credit unions managed by a subsidiary of Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), is pleased to welcome 29 new member companies that joined during the 2023 calendar year. The addition of these members amid the challenging mortgage origination environment is a testament to the power of the Cooperative’s mission of helping members maximize revenue, reduce the cost to manufacture loans and improve decisions through the sharing of best practices. Lenders One offers a suite of solutions including credit, flood, fraud, verifications and quality control that help originators lower their origination costs, while providing the same service...